SEARCH

SEARCH BY CITATION

References

  • Barnard, D.R., Lange, B., Alonzo, T.A., Buckley, J., Kobrinsky, J.N., Gold, S., Neudorf, S., Sanders, J., Burden, L. & Woods, W.G. (2002) Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation. Blood, 100, 427434.
  • Berthold, F., Hero, B., Kremens, B., Handgretinger, R., Henze, G., Schilling, F.H., Schrappe, M., Simon, T. & Spix, C. (2003) Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. Cancer letters, 197, 1117.
  • Bhatia, S., Sather, H.N., Pabustan, O.B., Trigg, M.E., Gaynon, P.S. & Robison, L.L. (2002) Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood, 99, 42574264.
  • Burkhardt, B., Zimmermann, M., Oschlies, I., Niggli, F., Mann, G., Parwaresch, R., Riehm, H., Schrappe, M. & Reiter, A. (2005) The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. British Journal Haematology, 131, 3949.
  • Burkhardt, B., Woessmann, W., Zimmermann, M., Kontny, U., Vormoor, J., Doerffel, W., Mann, G., Henze, G., Niggli, F., Ludwig, W.D., Janssen, D., Riehm, H., Schrappe, M. & Reiter, A. (2006) Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. Journal of Clinical Oncology, 24, 491499.
  • Cardous-Ubbink, M.C., Heinen, R.C., Bakker, P.J., Van Den Berg, H., Oldenburger, F., Caron, H.N., Voute, P.A. & Van Leeuwen, F.E. (2007) Risk of second malignancies in long-term survivors of childhood cancer. European Journal of Cancer, 43, 351362.
  • Carret, A.S., Tabori, U., Crooks, B., Hukin, J., Odame, I., Johnston, D.L., Keene, D.L., Freeman, C. & Bouffet, E. (2006) Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium. Radiotherapy and Oncology, 81, 3338.
  • Creutzig, U., Ritter, J., Zimmermann, M., Reinhardt, D., Hermann, J., Berthold, F., Henze, G., Jurgens, H., Kabisch, H., Havers, W., Reiter, A., Kluba, U., Niggli, F. & Gadner, H. (2001) Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93. Journal of Clinical Oncology, 19, 27052713.
  • Creutzig, U., Zimmermann, M., Lehrnbecher, T., Graf, N., Hermann, J., Niemeyer, C.M., Reiter, A., Ritter, J., Dworzak, M., Stary, J. & Reinhardt, D. (2006) Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Journal of Clinical Oncology, 24, 44994506.
  • Dopfer, R., Henze, G., Bender-Gotze, C., Ebell, W., Ehninger, G., Friedrich, W., Gadner, H., Klingebiel, T., Peters, C. & Riehm, H. (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood, 78, 27802784.
  • Eguiguren, J.M., Ribeiro, R.C., Pui, C.H., Hancock, M.L., Pratt, C.B., Head, D.R. & Crist, W.M. (1991) Secondary non-Hodgkin’s lymphoma after treatment for childhood cancer. Leukemia, 5, 908911.
  • Einsiedel, H.G., Von Stackelberg, A., Hartmann, R., Fengler, R., Schrappe, M., Janka-Schaub, G., Mann, G., Hahlen, K., Gobel, U., Klingebiel, T., Ludwig, W.D. & Henze, G. (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. Journal of Clinical Oncology, 23, 79427950.
  • Gatta, G., Capocaccia, R., Coleman, M.P., Ries, L.A. & Berrino, F. (2002) Childhood cancer survival in Europe and the United States. Cancer, 95, 17671772.
  • Gatta, G., Corazziari, I., Magnani, C., Peris-Bonet, R., Roazzi, P. & Stiller, C. (2003) Childhood cancer survival in Europe. Annals of Oncology, 14(Suppl. 5), v119v127.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J. (2001) WHO Classification, Tumours of Haematopoietic and Lymphoid Tissue. IARC Press, Lyon, France.
  • Jenkinson, H.C., Hawkins, M.M., Stiller, C.A., Winter, D.L., Marsden, H.B. & Stevens, M.C. (2004) Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. British Journal of Cancer, 91, 19051910.
  • Juergens, C., Weston, C., Lewis, I., Whelan, J., Paulussen, M., Oberlin, O., Michon, J., Zoubek, A., Juergens, H. & Craft, A. (2006) Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer, 47, 2229.
  • Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc, 53, 457481.
  • Loning, L., Zimmermann, M., Reiter, A., Kaatsch, P., Henze, G., Riehm, H. & Schrappe, M. (2000) Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood, 95, 27702775.
  • MacArthur, A.C., Spinelli, J.J., Rogers, P.C., Goddard, K.J., Abanto, Z.U. & McBride, M.L. (2007) Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada. Pediatr Blood Cancer, 48, 460467.
  • Moricke, A., Reiter, A., Zimmermann, M., Gadner, H., Stanulla, M., Dordelmann, M., Loning, L., Beier, R., Ludwig, W.D., Ratei, R., Harbott, J., Boos, J., Mann, G., Niggli, F., Feldges, A., Henze, G., Welte, K., Beck, J.D., Klingebiel, T., Niemeyer, C., Zintl, F., Bode, U., Urban, C., Wehinger, H., Niethammer, D., Riehm, H. & Schrappe, M. (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111, 44774485.
  • Murphy, S.B. (1980) Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Seminars in Oncology, 7, 332339.
  • Neglia, J.P., Friedman, D.L., Yasui, Y., Mertens, A.C., Hammond, S., Stovall, M., Donaldson, S.S., Meadows, A.T. & Robison, L.L. (2001) Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. Journal of the National Cancer Institute, 93, 618629.
  • Reiter, A., Schrappe, M., Parwaresch, R., Henze, G., Muller-Weihrich, S., Sauter, S., Sykora, K.W., Ludwig, W.D., Gadner, H. & Riehm, H. (1995) Non-Hodgkin’s lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Munster Group. Journal of Clinical Oncology, 13, 359372.
  • Reiter, A., Schrappe, M., Tiemann, M., Ludwig, W.D., Yakisan, E., Zimmermann, M., Mann, G., Chott, A., Ebell, W., Klingebiel, T., Graf, N., Kremens, B., Muller-Weihrich, S., Pluss, H.J., Zintl, F., Henze, G. & Riehm, H. (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood, 94, 32943306.
  • Reiter, A., Schrappe, M., Ludwig, W.D., Tiemann, M., Parwaresch, R., Zimmermann, M., Schirg, E., Henze, G., Schellong, G., Gadner, H. & Riehm, H. (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood, 95, 416421.
  • Riehm, H., Reiter, A., Schrappe, M., Berthold, F., Dopfer, R., Gerein, V., Ludwig, R., Ritter, J., Stollmann, B. & Henze, G. (1987) Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klinische Padiatrie, 199, 151160.
  • Robison, L.L. & Mertens, A. (1993) Second tumors after treatment of childhood malignancies. Hematology/oncology Clinics of North America, 7, 401415.
  • Schellong, G. (1998) Pediatric Hodgkin’s disease: treatment in the late 1990s. Annals of Oncology, 9(Suppl 5), S115S119.
  • Seidemann, K., Tiemann, M., Schrappe, M., Yakisan, E., Simonitsch, I., Janka-Schaub, G., Dorffel, W., Zimmermann, M., Mann, G., Gadner, H., Parwaresch, R., Riehm, H. & Reiter, A. (2001) Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood, 97, 36993706.
  • Steliarova-Foucher, E., Stiller, C., Kaatsch, P., Berrino, F., Coebergh, J.W., Lacour, B. & Parkin, M. (2004) Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet, 364, 20972105.
  • Timmermann, B., Kortmann, R.D., Kuhl, J., Meisner, C., Dieckmann, K., Pietsch, T. & Bamberg, M. (2002) Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. Journal of Clinical Oncology, 20, 842849.
  • Winkler, K., Beron, G., Delling, G., Heise, U., Kabisch, H., Purfurst, C., Berger, J., Ritter, J., Jurgens, H. & Gerein, V. (1988) Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. Journal of Clinical Oncology, 6, 329337.
  • Winkler, K., Bielack, S., Delling, G., Salzer-Kuntschik, M., Kotz, R., Greenshaw, C., Jurgens, H., Ritter, J., Kusnierz-Glaz, C., Erttmann, R., Gädicke, N., Graf, R., Ladenstein, S., Leyvraz, R., Mertens, P. & Weinel, P. (1990) Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer, 66, 17031710.
  • Woessmann, W., Seidemann, K., Mann, G., Zimmermann, M., Burkhardt, B., Oschlies, I., Ludwig, W.D., Klingebiel, T., Graf, N., Gruhn, B., Juergens, H., Niggli, F., Parwaresch, R., Gadner, H., Riehm, H., Schrappe, M. & Reiter, A. (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood, 105, 948958.
  • Zintl, F.M.H., Reimann, M., Hermann, J., Domula, M., Dörffel, W., Eggers, W., Exadaktylos, P., Hilgenfeld, E., Kotte, W., Krause, I., Kunert, W., Mittler, U., Möbius, D., Reddemann, H., Weißbach, G. & Weinmann, G. (1992) Experiences with modified BFM protocols in the treatment of children with acute lymphoblastic leukemai (ALL) in East Germany 1981-1991. Klinische Padiatrie, 204, 221229.